133 related articles for article (PubMed ID: 26802625)
1. The Phoneutria nigriventer spider toxin, PnTx4-5-5, promotes neuronal survival by blocking NMDA receptors.
Silva FR; Batista EM; Gomez MV; Kushmerick C; Da Silva JF; Cordeiro MN; Vieira LB; Ribeiro FM
Toxicon; 2016 Mar; 112():16-21. PubMed ID: 26802625
[TBL] [Abstract][Full Text] [Related]
2. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.
Zeron MM; Hansson O; Chen N; Wellington CL; Leavitt BR; Brundin P; Hayden MR; Raymond LA
Neuron; 2002 Mar; 33(6):849-60. PubMed ID: 11906693
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the recombinant toxin PnTx4(5-5) from the spider Phoneutria nigriventer on mammalian and insect sodium channels.
Paiva AL; Matavel A; Peigneur S; Cordeiro MN; Tytgat J; Diniz MR; de Lima ME
Biochimie; 2016 Feb; 121():326-35. PubMed ID: 26747232
[TBL] [Abstract][Full Text] [Related]
4. Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.
Doria JG; Silva FR; de Souza JM; Vieira LB; Carvalho TG; Reis HJ; Pereira GS; Dobransky T; Ribeiro FM
Br J Pharmacol; 2013 Jun; 169(4):909-21. PubMed ID: 23489026
[TBL] [Abstract][Full Text] [Related]
5. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
[TBL] [Abstract][Full Text] [Related]
6. Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies.
Calabresi P; Centonze D; Cupini LM; Costa C; Pisani F; Bernardi G
Neurobiol Dis; 2003 Feb; 12(1):82-8. PubMed ID: 12609492
[TBL] [Abstract][Full Text] [Related]
7. Phoneutria spider toxins block ischemia-induced glutamate release, neuronal death, and loss of neurotransmission in hippocampus.
Pinheiro AC; da Silva AJ; Prado MA; Cordeiro Mdo N; Richardson M; Batista MC; de Castro Junior CJ; Massensini AR; Guatimosim C; Romano-Silva MA; Kushmerick C; Gomez MV
Hippocampus; 2009 Nov; 19(11):1123-9. PubMed ID: 19370546
[TBL] [Abstract][Full Text] [Related]
8. NMDA receptor activation enhances inhibitory GABAergic transmission onto hippocampal pyramidal neurons via presynaptic and postsynaptic mechanisms.
Xue JG; Masuoka T; Gong XD; Chen KS; Yanagawa Y; Law SK; Konishi S
J Neurophysiol; 2011 Jun; 105(6):2897-906. PubMed ID: 21471392
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effect of PnTx4(5-5), a peptide from
Oliveira CFB; Alves DP; Emerich BL; de Figueiredo SG; Cordeiro MDN; Borges MH; Richardson M; Pimenta AMC; Duarte IDG; de Lima ME
J Venom Anim Toxins Incl Trop Dis; 2019; 25():e20190022. PubMed ID: 31467512
[TBL] [Abstract][Full Text] [Related]
10. PnTx4-3, a new insect toxin from Phoneutria nigriventer venom elicits the glutamate uptake inhibition exhibited by PhTx4 toxic fraction.
Oliveira LC; De Lima ME; Pimenta AM; Mansuelle P; Rochat H; Cordeiro MN; Richardson M; Figueiredo SG
Toxicon; 2003 Dec; 42(7):793-800. PubMed ID: 14757211
[TBL] [Abstract][Full Text] [Related]
11. δ-Ctenitoxin-Pn1a, a Peptide from Phoneutria nigriventer Spider Venom, Shows Antinociceptive Effect Involving Opioid and Cannabinoid Systems, in Rats.
Emerich BL; Ferreira RC; Cordeiro MN; Borges MH; Pimenta AM; Figueiredo SG; Duarte ID; de Lima ME
Toxins (Basel); 2016 Apr; 8(4):106. PubMed ID: 27077886
[TBL] [Abstract][Full Text] [Related]
12. Region-specific role for GluN2B-containing NMDA receptors in injury to Purkinje cells and CA1 neurons following global cerebral ischemia.
Quillinan N; Grewal H; Deng G; Shimizu K; Yonchek JC; Strnad F; Traystman RJ; Herson PS
Neuroscience; 2015 Jan; 284():555-565. PubMed ID: 25450957
[TBL] [Abstract][Full Text] [Related]
13. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
[TBL] [Abstract][Full Text] [Related]
14. Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice.
Martire A; Calamandrei G; Felici F; Scattoni ML; Lastoria G; Domenici MR; Tebano MT; Popoli P
Neurosci Lett; 2007 Apr; 417(1):78-83. PubMed ID: 17331645
[TBL] [Abstract][Full Text] [Related]
15. Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.
Starling AJ; André VM; Cepeda C; de Lima M; Chandler SH; Levine MS
J Neurosci Res; 2005 Nov; 82(3):377-86. PubMed ID: 16211559
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in Kv2 Channel Expression Shapes Action Potential Characteristics and Firing Patterns in CA1 versus CA2 Hippocampal Pyramidal Neurons.
Palacio S; Chevaleyre V; Brann DH; Murray KD; Piskorowski RA; Trimmer JS
eNeuro; 2017; 4(4):. PubMed ID: 28856240
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection against excitotoxicity by N-alkylglycines in rat hippocampal neurons.
Valera E; Fernández-Salguero PM; Planells-Cases R; Messeguer A; Van Den Nest W; Carreño C; Ferrer-Montiel A; Merino JM
Neuromolecular Med; 2002; 2(3):271-80. PubMed ID: 12622405
[TBL] [Abstract][Full Text] [Related]
18. Sigma-1 (σ₁) receptor deficiency reduces β-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B.
Yin J; Sha S; Chen T; Wang C; Hong J; Jie P; Zhou R; Li L; Sokabe M; Chen L
Neuropharmacology; 2015 Feb; 89():215-24. PubMed ID: 25286118
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
[TBL] [Abstract][Full Text] [Related]
20. Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death.
Seo SY; Yun BS; Ryoo IJ; Choi JS; Joo CK; Chang SY; Chung JM; Oh S; Gwag BJ; Yoo ID
J Pharmacol Exp Ther; 2001 Oct; 299(1):377-84. PubMed ID: 11561102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
